COMPUTED-TOMOGRAPHY, DIAGNOSIS, STAGING AND FOLLOW-UP OF PURE GRANULOSA-CELL TUMOR OF THE OVARY

被引:15
作者
MACSWEENEY, JE [1 ]
KING, DM [1 ]
机构
[1] ROYAL MARSDEN HOSP,DEPT RADIOL,FULHAM RD,LONDON SW3 6LP,ENGLAND
关键词
D O I
10.1016/S0009-9260(05)81848-3
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Granulosa theca cell tumours represent the largest group of hormone-secreting ovarian tumours and comprise approximately 1.5% of all ovarian malignancy. However, the prognosis and behaviour of pure granulosa cell tumours have been particularly difficult to evaluate, because in previous reports they have been grouped with granulosa theca cell tumours. Consequently, their radiological features and the possible contribution of computed tomography (CT) to clinical management has not been evaluated. We report the CT appearances of 15 patients with pure granulosa cell tumours and their clinical outcome. The results suggest the possibility of a positive relationship between histological grade and FIGO stage at presentation. Large tumour volume, extensive lymph node involvement and ascites on CT are adverse prognostic features. However, patients with abdominal masses less than 9 cm in diameter, absent or small volume lymph node disease and peritoneal and liver metastases achieved complete remission, suggesting that CT can assist in identifying those patients likely to respond best to current therapeutic regimens.
引用
收藏
页码:241 / 245
页数:5
相关论文
共 15 条
[1]  
BUSBY T, 1954, AM J OBSTET GYNECOL, V68, P1391
[2]   IMMUNOHISTOCHEMISTRY OF OVARIAN GRANULOSA-CELL TUMORS - THE VALUE OF TISSUE SPECIFIC PROTEINS AND TUMOR-MARKERS [J].
CHADHA, S ;
VANDERKWAST, TH .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1989, 414 (05) :439-445
[3]   COMPUTED-TOMOGRAPHY IN EVALUATION OF PATIENTS WITH OVARIAN-CARCINOMA IN COMPLETE CLINICAL REMISSION - CORRELATION WITH SURGICAL-PATHOLOGICAL FINDINGS [J].
CLARKEPEARSON, DL ;
BANDY, LC ;
DUDZINSKI, M ;
HEASTON, D ;
CREASMAN, WT .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (05) :627-630
[4]  
EVANS AT, 1980, OBSTET GYNECOL, V55, P231
[5]  
FOX H, 1975, CANCER, V35, P231, DOI 10.1002/1097-0142(197501)35:1<231::AID-CNCR2820350128>3.0.CO
[6]  
2-O
[7]  
NORRIS HJ, 1968, CANCER, V21, P255, DOI 10.1002/1097-0142(196802)21:2<255::AID-CNCR2820210214>3.0.CO
[8]  
2-5
[9]  
NOVAK ER, 1971, OBSTET GYNECOL, V38, P701
[10]  
PANKRATZ E, 1978, OBSTET GYNECOL, V52, P718